Table 1 Baseline information for two groups of patients.
Characteristics | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
CLR (N = 106) | NOSES (N = 59) | p value | CLR (N = 59) | NOSES (N = 59) | p value | |
Gender (N,%) | 0.16 | 0.46 | ||||
Male | 64(60.4%) | 29(49.2%) | 33(44.1%) | 29(49.2%) | ||
Female | 42(39.6%) | 30(50.8%) | 26(55.9%) | 30(50.8%) | ||
Age (years)a | 59.8 ± 10.4 | 59.6 ± 12.1 | 0.92 | 60.4 ± 9.7 | 59.6 ± 12.1 | 0.69 |
BMI (kg/m2)a | 23.0 ± 2.9 | 23.3 ± 2.7 | 0.40 | 23.1 ± 2.9 | 23.3 ± 2.7 | 0.66 |
ASA grade (N,%) | 0.76 | 0.81 | ||||
I/II | 86(81.1%) | 49(83.1%) | 48(81.4%) | 49(83.1%) | ||
III | 20(18.9%) | 10(16.9%) | 11(18.6%) | 10(16.9%) | ||
Preoperative CEA (N,%)b | 0.76 | 0.80 | ||||
Positive | 20(18.9%) | 10(16.9%) | 9(15.3%) | 10(16.9%) | ||
Negative | 86(81.1%) | 49(83.1%) | 50(84.7%) | 49(83.1%) | ||
T Stage (N,%) | 0.27 | 0.71 | ||||
Tis/T1 | 20(18.9%) | 14(23.7%) | 11(18.6%) | 14(23.7%) | ||
T2 | 29(27.3%) | 21(35.6%) | 20(33.9%) | 21(35.6%) | ||
T3 | 57(53.8%) | 24(40.7%) | 28(47.5%) | 24(40.7%) | ||
N Stage (N,%) | 0.76 | 0.68 | ||||
N0 | 73(68.9%) | 42(71.2%) | 44(74.6%) | 42(71.2%) | ||
N1/N2 | 33(31.1%) | 17(28.8%) | 15(25.4%) | 17(28.8%) | ||
Preoperative PFDI-20a | 7.11 ± 2.11 | 6.98 ± 1.65 | 0.68 | 7.05 ± 2.01 | 6.98 ± 1.65 | 0.84 |